Belgian CDMO offers new LNP service as demand for RNA-delivery services heats up
In Belgium, eTheRNA has been working with mRNA since 2013, long before the Covid-19 pandemic was on anyone’s mind, and long before the success of the molecule was well-documented.
And while it has watched several companies such as Moderna and Pfizer quickly figure out a way to manufacture the molecule and deliver it to those who need it, that process was conceived at lightning speed, and COO Bernard Sagaert believes that his team can improve upon it.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.